RNA-Logix connects biological questions, experimental evidence, and RNA medicine design in a single investigative workflow.

La Trobe University is now home to one of the world's leading biopharmaceutical companies, with the official opening of BioNTech's state-of-the-art ...

The clinical-scale mRNA manufacturing and R&D facility is one of three strategic pillars of BioNTech's presence in Australia, which is focused on contributing to the local mRNA ecosystem as well as ...

ScionxBio (the "company", operating as a brand identity of Eleven Therapeutics Ltd. following a horizontal split) a privately ...

The collaboration will combine Sanofi’s mRNA drug candidates with ScionxBio’s AI-driven TERA platform to develop ...

Sierk Poetting, Ph.D., Chief Operating Officer at BioNTech said: “Our partnership with the Victorian Government demonstrates how public-private collaboration can build lasting c ...

A new review describes how the RNA methyltransferase METTL5 and the detox enzyme MGST1 form a signaling axis that helps ...

When the coronavirus SARS-CoV-2 turned our world upside down, mRNA vaccines against COVID-19 brought a breakthrough. Their ...

Many treatments for prostate cancer, one of the most common cancers in men, target a protein called the androgen receptor, ...

Poulis, P.; Robecchi, G.; Kurochkina, A. O.; Felletti, M.; Rodnina, M. V. Recoding by N1-methylpseudouridine guides rational mRNA vaccine design. Nature Communications (2026).

Scientists discover why ribosomes misread certain modified mRNA sequences and show how simple sequence changes could improve vaccine design and safety.

Up more than 11%; as of press time, it was up 11.15% at HK$32.9, with trading volume nearing HK$200 million.On the new ...